The IL-1 Family and Its Role in Atherosclerosis.

Int J Mol Sci · 2022 · PMC9820551 · PMID 36613465

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Finally, a randomized, phase II trial looking at the effect of Xilonix—an anti-IL-1α antibody—on neointimal hyperplasia and post-procedural inflammation in the superficial femoral artery after angioplasty, showed a trend towards a reduction in restenosis [ 152 ]. 6.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.